AUGUSTIN, M.; WEGTOWSKA, J.; LEBWOHL, M.; PAUL, C.; PIGUET, V.; SOFEN, H.; BLAUVELT, A.; PETERSON, L.; AL., E. Durability of Response in Patients with Chronic Plaque Psoriasis Treated with Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S87, 2018. DOI: 10.25251/skin.2.supp.88. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/484. Acesso em: 3 jul. 2024.